Cancer BiologybioRxiv
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming
X. Lu, K. W. Fong, G. Gritsina…·J. Yu
This study identifies HOXB13's AR-independent role in suppressing lipogenesis via HDAC3-mediated epigenetic repression, linking its loss to metastatic prostate cancer progression.
DOI 10.1038/s41588-022-01045-8